Skip to main content

Table 2 Demographics of the study population

From: Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study

Demographic variables

Study population (n = 66)

 Gender (male)

41 (62%)

 Height (cm)

166.3 ± 7.9

 BMI (kg/m2)

26.9 ± 4.5

 Age (years)

73 ± 12

 Smoking

17 (26%)

 Fistula

27 (41%)

 Hickmann Catheter

39 (59%)

 KT/V

1.41 ± 0.20

 Dialysis vintage (months)

49.2 ± 46.8

 Median UFV (mL)

1800 [1100–2400]

 Predialysis SBP/DBP (mmHg)

134.9 ± 22.1 / 64.3 ± 15.0

 Postdialysis SBP/DBP (mmHg)

129.5 ± 20.3 / 63.5 ± 12.6

Etiology of End-Stage Renal Disease

 Diabetic Kidney Disease

16 (24%)

 Non-diabetic Kidney Disease

53 (80%)

Comorbidities

 Cardiac Diseasea

39 (59%)

 Lung Disease (COPD)

7 (11%)

 Arterial Hypertension

47 (71%)

 Diabetes

29 (44%)

 Overweight

26 (39%)

 Obesity

15 (23%)

  1. aCardiac diseases identified within the study population: cardiomyopathy, systolic dysfunction, ischemic heart failure, decompensated heart failure, heart failure with reduced ejection fraction, coronary artery bypass grafting surgery, aortic valve stenosis and replacement, myocardial infarction, ventricular fibrillation and flutter, the presence of cardiac implantable electronic devices (e.g. pacemaker), atrial fibrillation, bundle branch block, left ventricular hypertrophy
  2. COPD chronic obstructive pulmonary disease; DBP diastolic blood pressure; SBP systolic blood pressure; UFV ultrafiltration volume